A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads.
10.3350/kjhep.2010.16.4.405
- Author:
Dong Hoo JOH
1
;
Jin Dong KIM
;
Young Nam KIM
;
Ha Hun SONG
;
Hyun KIM
;
Kyung Ho SONG
;
Sang Jin LEE
;
Jeong Rok LEE
;
Won Joong JEON
;
Byung Hyo CHA
Author Information
1. Department of Internal Medicine, Cheju Halla General Hospital, Jeju, Korea. motet76@gmail.com
- Publication Type:Case Report
- Keywords:
Carcinoma, Hepatocellular;
Chemoembolization;
Drug-eluting beads;
Caudate lobe
- MeSH:
Carcinoma, Hepatocellular/*therapy;
Chemoembolization, Therapeutic;
Doxorubicin/administration & dosage;
Drug-Eluting Stents;
Humans;
Liver Neoplasms/*therapy;
Magnetic Resonance Imaging;
Male;
Neoplasm Staging;
Tomography, X-Ray Computed
- From:The Korean Journal of Hepatology
2010;16(4):405-409
- CountryRepublic of Korea
- Language:English
-
Abstract:
Hepatocellular carcinoma (HCC) in the caudate lobe remains one of the most intricate locations where various treatments tend to pose problems with regard to the optimal approach. Surgical resection has been regarded as the most effective treatment; however, isolated resection of the caudate lobe is strenuous and associated with a high rate of early recurrence. Percutaneous ablation might be technically difficult or impossible to perform due to the deep location of tumors and adjacent large vessels. Treatment with drug-eluting beads (DEB) can potentially enhance the therapeutic efficacy for patients with unresectable HCC by drawing on the slower, more consistent drug delivery process. We described a case of a 62-year-old man with HCC in the caudate lobe who was successfully treated by DEB.
